Allergic Reactions
Q&A: Company seeks to expand neffy FDA approval to more pediatric patients
ARS Pharmaceuticals announced its submission of a supplemental new drug application to the FDA for neffy 1 mg for the treatment of type 1 allergic reactions in children who weigh between 33 lb and 66 lb.
Top news of August: FDA neffy approval, women’s asthma health, APA-AAI conference, more
Healio has compiled August’s most-read news in asthma and allergy.
EURneffy adrenaline nasal spray approved for use in the EU
The European Commission has approved EURneffy for the emergency treatment of allergic reactions, according to a press release by ARS Pharmaceuticals, producer of the drug.
Top in allergy/asthma: FDA OKs neffy nasal spray; cleaning products pose risks for women
The FDA approved ARS Pharmaceuticals’ neffy epinephrine nasal spray for emergency allergic reactions in children and adults weighing at least 66 pounds.
Women may face greater allergy, respiratory risks from household cleaning product use
Women traditionally spend significantly more time than men completing housework such as cooking and cleaning, putting them at risk for higher exposures to harmful agents that are known to cause respiratory and allergic issues, experts said.
Oral therapy for cow’s milk allergy may show better adherence than in other allergens
Participants with an allergy to cow’s milk had the lowest rate of oral immunotherapy treatment discontinuation, according to a study published in Annals of Allergy, Asthma and Immunology.
Most caregivers of children with food allergies go online at least weekly for information
More patients are using online platforms to obtain information on food, trusting professional organizations and allergists the most, according to a study published in Annals of Allergy and Asthma and Immunology.
Biologics
Suntegrity Skincare recalls Impeccable Skin Sunscreen Foundation
Suntegrity Skincare has issued a voluntary recall of nine Impeccable Skin Sunscreen Foundation lots, according to a press release from the FDA.
Invisible ink for radiation may improve patient quality of life
A novel invisible ink tattoo technique may improve long-term quality of life and emotional well-being for people with cancer who undergo radiation therapy, according to study results.